Policy and Advocacy News
Policy and Advocacy News
-
When Grants End, So Do Scientific Breakthroughs
New analysis from amfAR’s Public Policy Office assesses the human cost of terminated federal research grants focused on cancer.
-
24 Hours to Save AIDS Research
A global campaign—24 Hours to Save AIDS Research—draws on expertise of researchers and advocates to call for sustained U.S. funding for HIV research.
-
Community-Led Health Programs Benefit People Impacted by HIV
New amfAR-funded study—the SCOPE report—shows how local experts are essential to Global Fund-supported healthcare delivery.
-
Title X Restrictions Harm the U.S. HIV Response
New amfAR analysis of Title X funding restrictions shows that ending the HIV epidemic is jeopardized when federal limits are placed on family planning services.
-
Progress on HIV—Derailed
The latest UNAIDS report shows advances in the global HIV response but warns funding cuts are creating a crisis for millions of people impacted by HIV.
-
FDA Approves Lenacapavir for HIV Pre-Exposure Prophylaxis
The FDA-approved lenacapavir for PrEP holds the potential to dramatically reduce HIV infections with its adherence-friendly twice-annual injection.
-
amfAR Report Details How PEPFAR Support Allowed Governments to Strengthen Health Systems
Domestic healthcare spending and capacity growth in PEPFAR countries exceeds non-PEPFAR countries, as detailed by amfAR, The Foundation for AIDS Research.
-
Cuts to the CDC’s Division of HIV Prevention Will Lead to Dramatic Rise in Infections, Deaths, and Costs
Without funding, there will be a loss of momentum in reducing HIV cases, and the nation’s epidemic will worsen significantly.
-
President Trump’s HIV Plan Is Too Valuable to Lose
amfAR analyses show states that implemented EHE would avert significantly more HIV treatment costs by 2030.
-
The Hidden Cost of Capping NIH Indirect Costs: How Students Pay the Price
Revision of federal grant policy for health research would deal economic blow to roughly 600 U.S. universities and university systems
-
The Best Investment You Didn’t Know You Made: How NIH Funding Fuels Innovation and Economic Growth
Continued investment in the NIH is essential to fighting current and emerging health threats and to ensuring the U.S. remains a global leader in medical innovation.
-
Assessing the Impact of the PEPFAR Stop Work Order
An analysis by amfAR and other advocacy groups shows that the Trump Administration’s HIV funding freeze is reversing hard-won progress toward ending AIDS.
-
Supporting Health Advocacy from the Ground Up
In collaboration with the group Data, Et cetera, amfAR’s public policy office has published a new issue brief that examines the Global Fund’s efforts to strengthen community-focused HIV/AIDS programming.
-
Science, Public Health, and Advocacy Converge at amfAR + M•A•C Event
To commemorate World AIDS Day, amfAR and M•A•C Cosmetics hosted a panel discussion that covered HIV cure research, advocacy, and public health.
-
Take the Rights Path
A new UNAIDS report, Take the Rights Path to End AIDS, links the promotion of human rights to improved HIV healthcare.